RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
Detection of NRG1 gene fusions in solid tumors. https://t.co/8uhyJwGlFK
RT @ChristianRolfo: Detection of NRG1 gene fusions in solid tumors | Clinical Cancer Research. Congrats to @StephenVLiu , @HosseinBorghaei…
RT @ChristianRolfo: Detection of NRG1 gene fusions in solid tumors | Clinical Cancer Research. Congrats to @StephenVLiu , @HosseinBorghaei…
RT @ChristianRolfo: Detection of NRG1 gene fusions in solid tumors | Clinical Cancer Research. Congrats to @StephenVLiu , @HosseinBorghaei…
RT @Aiims1742: NRG1 fusions in solid tumors - survey of >21,000 cases with targeted RNA Seq using the ArcherDx FusionPlex panel. Another ex…
RT @Aiims1742: NRG1 fusions in solid tumors - survey of >21,000 cases with targeted RNA Seq using the ArcherDx FusionPlex panel. Another ex…
RT @ChristianRolfo: Detection of NRG1 gene fusions in solid tumors | Clinical Cancer Research. Congrats to @StephenVLiu , @HosseinBorghaei…
RT @ChristianRolfo: Detection of NRG1 gene fusions in solid tumors | Clinical Cancer Research. Congrats to @StephenVLiu , @HosseinBorghaei…
Detection of NRG1 gene fusions in solid tumors | Clinical Cancer Research. Congrats to @StephenVLiu , @HosseinBorghaei and all the authors! https://t.co/KIdoXpDtyu
RT @Aiims1742: NRG1 fusions in solid tumors - survey of >21,000 cases with targeted RNA Seq using the ArcherDx FusionPlex panel. Another ex…
RT @mlazqui: Detection of NRG1 gene fusions in solid tumors | Clinical Cancer Research https://t.co/P1j8p3fCb6
RT @susanahprieto: Detection of NRG1 gene fusions in solid tumors 🎯 https://t.co/2weJmuwOfw
RT @Aiims1742: NRG1 fusions in solid tumors - survey of >21,000 cases with targeted RNA Seq using the ArcherDx FusionPlex panel. Another ex…
RT @susanahprieto: Detection of NRG1 gene fusions in solid tumors 🎯 https://t.co/2weJmuwOfw
RT @Aiims1742: NRG1 fusions in solid tumors - survey of >21,000 cases with targeted RNA Seq using the ArcherDx FusionPlex panel. Another ex…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @mlazqui: Detection of NRG1 gene fusions in solid tumors | Clinical Cancer Research https://t.co/P1j8p3fCb6
RT @carisls: Caris researchers & @StephenVLiu of @LombardiCancer find rare but important gene targets in many tumor types, suggesting alter…
RT @OncoAlert: Just Out on @CCR_AACR : “Detection of NRG1 gene fusions in solid tumors” by @OncoAlert Onc @StephenVLiu of @LombardiCancer…
Detection of NRG1 gene fusions in solid tumors | Clinical Cancer Research https://t.co/P1j8p3fCb6
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @OncoAlert: Just Out on @CCR_AACR : “Detection of NRG1 gene fusions in solid tumors” by @OncoAlert Onc @StephenVLiu of @LombardiCancer…
RT @susanahprieto: Detection of NRG1 gene fusions in solid tumors 🎯 https://t.co/2weJmuwOfw
Just Out on @CCR_AACR : “Detection of NRG1 gene fusions in solid tumors” by @OncoAlert Onc @StephenVLiu of @LombardiCancer and team. A rare yet important gene target in many tumor types! https://t.co/uiubub8lc0 https://t.co/gaDJytqVFk
RT @carisls: Caris researchers & @StephenVLiu of @LombardiCancer find rare but important gene targets in many tumor types, suggesting alter…
RT @Aiims1742: NRG1 fusions in solid tumors - survey of >21,000 cases with targeted RNA Seq using the ArcherDx FusionPlex panel. Another ex…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @Aiims1742: NRG1 fusions in solid tumors - survey of >21,000 cases with targeted RNA Seq using the ArcherDx FusionPlex panel. Another ex…
RT @Aiims1742: NRG1 fusions in solid tumors - survey of >21,000 cases with targeted RNA Seq using the ArcherDx FusionPlex panel. Another ex…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @Aiims1742: NRG1 fusions in solid tumors - survey of >21,000 cases with targeted RNA Seq using the ArcherDx FusionPlex panel. Another ex…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @susanahprieto: Detection of NRG1 gene fusions in solid tumors 🎯 https://t.co/2weJmuwOfw
RT @carisls: Caris researchers & @StephenVLiu of @LombardiCancer find rare but important gene targets in many tumor types, suggesting alter…
Detection of NRG1 gene fusions in solid tumors https://t.co/tDJu3aXxgp
RT @Aiims1742: NRG1 fusions in solid tumors - survey of >21,000 cases with targeted RNA Seq using the ArcherDx FusionPlex panel. Another ex…
NRG1 fusions in solid tumors - survey of >21,000 cases with targeted RNA Seq using the ArcherDx FusionPlex panel. Another example of a low frequency fusion event with actionable potential. What’s the cost benefit ratio of upfront ArcherDx v IHC screenin
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @susanahprieto: Detection of NRG1 gene fusions in solid tumors 🎯 https://t.co/2weJmuwOfw
RT @susanahprieto: Detection of NRG1 gene fusions in solid tumors 🎯 https://t.co/2weJmuwOfw
RT @susanahprieto: Detection of NRG1 gene fusions in solid tumors 🎯 https://t.co/2weJmuwOfw
RT @susanahprieto: Detection of NRG1 gene fusions in solid tumors 🎯 https://t.co/2weJmuwOfw
Detection of NRG1 gene fusions in solid tumors 🎯 https://t.co/2weJmuwOfw
RT @carisls: Caris researchers & @StephenVLiu of @LombardiCancer find rare but important gene targets in many tumor types, suggesting alter…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
RT @StephenVLiu: #OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic act…
#OncoAlert Online now @CCR_AACR , characterization of #NRG1 fusions across solid tumor types. Potential tumor agnostic actionable alteration seen in NSCLC, colon cancer, RCC, pancreatic cancer and more. https://t.co/KqMG2sES6j
RT @carisls: Caris researchers & @StephenVLiu of @LombardiCancer find rare but important gene targets in many tumor types, suggesting alter…
RT @carisls: Caris researchers & @StephenVLiu of @LombardiCancer find rare but important gene targets in many tumor types, suggesting alter…
Caris researchers & @StephenVLiu of @LombardiCancer find rare but important gene targets in many tumor types, suggesting alternative therapy may be possible. NRG1 findings reported in @CCR_AACR today. More: https://t.co/8Har3jd6fe